131 related articles for article (PubMed ID: 36084253)
1. Thyroid Oncocytic (Hürthle Cell) Nodules With Longitudinal Nuclear Grooves: Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 15 Cases.
Suster D; Mackinnon AC; Suster S
Arch Pathol Lab Med; 2023 Jun; 147(6):684-691. PubMed ID: 36084253
[TBL] [Abstract][Full Text] [Related]
2. Solid Thyroid Follicular Nodules With Longitudinal Nuclear Grooves.
Suster D; Mackinnon AC; Nosé V; Suster S
Arch Pathol Lab Med; 2022 Aug; 146(8):984-993. PubMed ID: 34739542
[TBL] [Abstract][Full Text] [Related]
3. Fine-needle aspirations of papillary carcinoma with oncocytic features: an expanded cytologic and histologic profile.
Renshaw AA
Cancer Cytopathol; 2011 Aug; 119(4):247-53. PubMed ID: 21400667
[TBL] [Abstract][Full Text] [Related]
4. Benign Hürthle cell adenoma with papillary architecture: a benign lesion mimicking oncocytic papillary carcinoma.
Mai KT; Elmontaser G; Perkins DG; Thomas J; Stinson WA
Int J Surg Pathol; 2005 Jan; 13(1):37-41. PubMed ID: 15735853
[TBL] [Abstract][Full Text] [Related]
5. Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hürthle cell and/or apocrine-like changes.
Mai KT; Bokhary R; Yazdi HM; Thomas J; Commons AS
Histopathology; 2002 Feb; 40(2):133-42. PubMed ID: 11952857
[TBL] [Abstract][Full Text] [Related]
6. Psammomatous calcifications in thyroid oncocytic (Hürthle cell) follicular tumors.
Ronen N; Suster D
Ann Diagn Pathol; 2023 Feb; 62():152061. PubMed ID: 36459776
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules.
Mai KT; Ford JC; Yazdi HM; Perkins DG; Commons AS
Pathol Res Pract; 2000; 196(8):533-40. PubMed ID: 10982016
[TBL] [Abstract][Full Text] [Related]
8. The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases.
Berho M; Suster S
Hum Pathol; 1997 Jan; 28(1):47-53. PubMed ID: 9013831
[TBL] [Abstract][Full Text] [Related]
9. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
[TBL] [Abstract][Full Text] [Related]
10. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
11. Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma.
Mai KT; Landry DC; Thomas J; Burns BF; Commons AS; Yazdi HM; Odell PF
Histopathology; 2001 Jul; 39(1):25-32. PubMed ID: 11454041
[TBL] [Abstract][Full Text] [Related]
12. Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.
Lukovic J; Petrovic I; Liu Z; Armstrong SM; Brierley JD; Tsang R; Pasternak JD; Gomez-Hernandez K; Liu A; Asa SL; Mete O
Front Endocrinol (Lausanne); 2021; 12():795184. PubMed ID: 34975765
[TBL] [Abstract][Full Text] [Related]
13. Hurthle cells in fine needle aspiration cytology of the thyroid: a potential diagnostic dilemma?
Wong YP; Md Isa N; Md Zin RR; Noor Akmal S
Malays J Pathol; 2015 Apr; 37(1):49-52. PubMed ID: 25890614
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
Jung CK; Kim Y; Jeon S; Jo K; Lee S; Bae JS
Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601
[TBL] [Abstract][Full Text] [Related]
15. Oncocytic nodular hyperplasia of the thyroid.
Suster D; Ronen N; Giorgadze T
Ann Diagn Pathol; 2022 Dec; 61():152049. PubMed ID: 36162158
[TBL] [Abstract][Full Text] [Related]
16. Oncocytic Follicular Cell-Derived Thyroid Tumors With Papillary Growth Pattern: A Clinicopathologic Study of 32 Cases.
Suster D; Ronen N; Giorgadze T; Baisre-de Leon A; Montalvan I; Suster S
Arch Pathol Lab Med; 2023 Dec; ():. PubMed ID: 38100177
[TBL] [Abstract][Full Text] [Related]
17. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].
Tong J; Wang Y; Da JP
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):599-604. PubMed ID: 22325220
[TBL] [Abstract][Full Text] [Related]
19. Hybrid thyroid carcinoma with a coarse chromatin pattern and nuclear features of papillary thyroid carcinoma.
Mai KT; Bokhary R; Yazdi HM; Thomas J
Pathol Res Pract; 2002; 198(4):253-60. PubMed ID: 12049333
[TBL] [Abstract][Full Text] [Related]
20. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
